NASDAQ:CBUS Cibus (CBUS) Stock Price, News & Analysis $1.59 +0.08 (+5.23%) Closing price 03:50 PM EasternExtended Trading$1.58 -0.01 (-0.50%) As of 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Cibus Stock (NASDAQ:CBUS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cibus alerts:Sign Up Key Stats Today's Range$1.51▼$1.5950-Day Range$1.38▼$3.3652-Week Range$1.38▼$10.77Volume213,936 shsAverage Volume232,953 shsMarket Capitalization$51.90 millionP/E RatioN/ADividend YieldN/APrice Target$22.00Consensus RatingBuy Company Overview Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California. Read More Cibus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks49th Percentile Overall ScoreCBUS MarketRank™: Cibus scored higher than 49% of companies evaluated by MarketBeat, and ranked 102nd out of 153 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingBuy Consensus RatingCibus has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageCibus has only been the subject of 1 research reports in the past 90 days.Read more about Cibus' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Cibus are expected to decrease in the coming year, from ($2.96) to ($3.02) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cibus is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cibus is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCibus has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cibus' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.28% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Cibus has recently increased by 5.71%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCibus does not currently pay a dividend.Dividend GrowthCibus does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted6.28% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Cibus has recently increased by 5.71%, indicating that investor sentiment is decreasing significantly. News and Social Media2.7 / 5News Sentiment0.93 News SentimentCibus has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Cibus this week, compared to 3 articles on an average week.Search Interest2 people have searched for CBUS on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added Cibus to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cibus insiders have not sold or bought any company stock.Percentage Held by Insiders31.16% of the stock of Cibus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.81% of the stock of Cibus is held by institutions.Read more about Cibus' insider trading history. Receive CBUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cibus and its competitors with MarketBeat's FREE daily newsletter. Email Address CBUS Stock News HeadlinesWhat is Sidoti Csr's Forecast for Cibus Q2 Earnings?June 27, 2025 | americanbankingnews.comThe U.S. Food and Drug Administration Completes Review of Cibus' Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock FeedJune 24, 2025 | globenewswire.comYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.July 3 at 2:00 AM | Priority Gold (Ad)Cibus Slides on Alliance with John Innes CentreJune 12, 2025 | baystreet.caCibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in FarmingJune 12, 2025 | globenewswire.comCibus, Inc. Announces Closing of $27.5 Million Public Offering | CBUS Stock NewsJune 9, 2025 | gurufocus.comCibus, Inc. Announces Closing of $27.5 Million Public OfferingJune 9, 2025 | gurufocus.comCibus, Inc. Closes $27.5 Million Public Offering of Class A Common StockJune 9, 2025 | quiverquant.comQSee More Headlines CBUS Stock Analysis - Frequently Asked Questions How have CBUS shares performed this year? Cibus' stock was trading at $2.78 at the beginning of 2025. Since then, CBUS stock has decreased by 43.2% and is now trading at $1.58. How were Cibus' earnings last quarter? Cibus, Inc. (NASDAQ:CBUS) issued its earnings results on Thursday, May, 8th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.70) by $0.04. The firm had revenue of $1.03 million for the quarter, compared to analyst estimates of $1.15 million. Cibus had a negative trailing twelve-month return on equity of 53.20% and a negative net margin of 5,784.87%. When did Cibus IPO? Cibus (CBUS) raised $100 million in an initial public offering (IPO) on Thursday, February 14th 2019. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Piper Jaffray served as the underwriters for the IPO. How do I buy shares of Cibus? Shares of CBUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cibus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cibus investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Advanced Micro Devices (AMD), Visa (V), Netflix (nflx) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings5/08/2025Today7/03/2025Next Earnings (Estimated)8/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry AGRI OPERATIONS Sub-IndustryChemicals Current SymbolNASDAQ:CBUS Previous SymbolNASDAQ:CBUS CIK1705843 Webwww.cibus.com Phone(858) 450-0008FaxN/AEmployees48Year FoundedN/APrice Target and Rating Average Stock Price Target$22.00 High Stock Price Target$25.00 Low Stock Price Target$17.50 Potential Upside/Downside+1,292.4%Consensus RatingBuy Rating Score (0-4)3.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($10.98) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$251.39 million Net Margins-5,784.87% Pretax Margin-6,422.14% Return on Equity-53.20% Return on Assets-18.04% Debt Debt-to-Equity RatioN/A Current Ratio1.23 Quick Ratio1.23 Sales & Book Value Annual Sales$4.26 million Price / Sales12.11 Cash Flow$4.16 per share Price / Cash Flow0.38 Book Value$3.11 per share Price / Book0.51Miscellaneous Outstanding Shares32,660,000Free Float22,482,000Market Cap$51.60 million OptionableOptionable Beta1.69 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (NASDAQ:CBUS) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cibus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cibus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.